Back to Search Start Over

Genetic loci associated with prevalent and incident myocardial infarction and coronary heart disease in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium

Authors :
Marcus Dörr
Vilmundur Gudnason
Brian G. Kral
Xiuqing Guo
Eric Boerwinkle
Stefan Weiss
Stephen S. Rich
Wendy S. Post
Albert V. Smith
Shih-Jen Hwang
Paul S. de Vries
Kent D. Taylor
Daniel I. Chasman
Lisa R. Yanek
Paul M. Ridker
Alanna C. Morrison
Bruce M. Psaty
Traci M. Bartz
Christopher J. O'Donnell
Franco Giulianini
Jie Yao
Nona Sotoodehnia
Mary F. Feitosa
Yi-Ping Fu
Fernando Rivadeneira
Lewis C. Becker
Abbas Dehghan
Joshua C. Bis
Tamara B. Harris
Lenore J. Launer
Rasika A. Mathias
Diane M. Becker
Uwe Völker
Yii-Der Ida Chen
Henry Völzke
Kenneth Rice
Jerome I. Rotter
Marcello Ricardo Paulista Markus
Albert Hofman
Julie Hahn
Oscar H. Franco
André G. Uitterlinden
Megan L. Grove
Jennifer A. Brody
Michael R. Brown
Dubé, Marie-Pierre
Epidemiology
Internal Medicine
Source :
PloS one, vol 15, iss 11, PLoS ONE, PLoS One (print), 15(11 November):e0230035. Public Library of Science, PLoS ONE, Vol 15, Iss 11, p e0230035 (2020)
Publication Year :
2020

Abstract

Background Genome-wide association studies have identified multiple genomic loci associated with coronary artery disease, but most are common variants in non-coding regions that provide limited information on causal genes and etiology of the disease. To overcome the limited scope that common variants provide, we focused our investigation on low-frequency and rare sequence variations primarily residing in coding regions of the genome. Methods and results Using samples of individuals of European ancestry from ten cohorts within the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, both cross-sectional and prospective analyses were conducted to examine associations between genetic variants and myocardial infarction (MI), coronary heart disease (CHD), and all-cause mortality following these events. For prevalent events, a total of 27,349 participants of European ancestry, including 1831 prevalent MI cases and 2518 prevalent CHD cases were used. For incident cases, a total of 55,736 participants of European ancestry were included (3,031 incident MI cases and 5,425 incident CHD cases). There were 1,860 all-cause deaths among the 3,751 MI and CHD cases from six cohorts that contributed to the analysis of all-cause mortality. Single variant and gene-based analyses were performed separately in each cohort and then meta-analyzed for each outcome. A low-frequency intronic variant (rs988583) in PLCL1 was significantly associated with prevalent MI (OR = 1.80, 95% confidence interval: 1.43, 2.27; P = 7.12 × 10−7). We conducted gene-based burden tests for genes with a cumulative minor allele count (cMAC) ≥ 5 and variants with minor allele frequency (MAF) < 5%. TMPRSS5 and LDLRAD1 were significantly associated with prevalent MI and CHD, respectively, and RC3H2 and ANGPTL4 were significantly associated with incident MI and CHD, respectively. No loci were significantly associated with all-cause mortality following a MI or CHD event. Conclusion This study identified one known locus (ANGPTL4) and four new loci (PLCL1, RC3H2, TMPRSS5, and LDLRAD1) associated with cardiovascular disease risk that warrant further investigation.

Details

Language :
English
ISSN :
19326203
Volume :
15
Issue :
11
Database :
OpenAIRE
Journal :
PLoS One (print)
Accession number :
edsair.doi.dedup.....f08ba115b3ce8f5520bc98edc09de30e